Rep. Khanna Presses FDA to Approve Rapid, Affordable In-Home Paper-Strip COVID-19 Testing
September 11, 2020
September 11, 2020
WASHINGTON, Sept. 11 -- Rep. Ro Khanna, D-California, issued the following news release on Sept. 10:
Today, Rep. Ro Khanna (D-CA) led a bipartisan group of thirteen Members of Congress in sending a letter to the Food and Drug Administration (FDA) urging the agency to consider an expedited authorization and modified sensitivity standards for low-cost, rapid, in-home coronavirus tests. Recognizing that frequent, affordable testing is necessary to return to normalcy--absent an authoriz . . .
Today, Rep. Ro Khanna (D-CA) led a bipartisan group of thirteen Members of Congress in sending a letter to the Food and Drug Administration (FDA) urging the agency to consider an expedited authorization and modified sensitivity standards for low-cost, rapid, in-home coronavirus tests. Recognizing that frequent, affordable testing is necessary to return to normalcy--absent an authoriz . . .